Loading insider details...
Beta
Latest Form 4 (Aug 11, 2026): Exercise/Conversion of 1,600 PCSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Exercise/Conversion | 1,600 | n/a |
| Jul 29, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 9,384 | n/a |
| Jul 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 3,057 | $5.9K |
| Jun 16, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,465 | $5.5K |
| Jun 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,129 | $5.5K |
| May 19, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,843 | $5.5K |
| May 19, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,843 | $5.5K |
| May 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,034 | $5.5K |
| Apr 30, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,136 | $5.4K |
| Feb 17, 2026 | TuHURA Biosciences, Inc./NV (HURA) | Grant/Award | 156,240 | n/a |